Xinrui Zhu - Publications

Acute Suppurative Phlegmonous Esophagogastritis Complicated by Esophagopleural Fistula.

Journal: Digestive diseases and sciences

Published: January 20, 2026

Minimally invasive treatment strategies for submucosal tumors of the upper gastrointestinal tract: Advances in innovative endoscopy-based therapies.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: November 17, 2024

Lenvatinib plus transarterial chemoembolization and PD-1 inhibitors as conversion therapies for unresectable intermediate-advanced hepatocellular carcinoma: a phase 2 trial and exploratory biomolecular study.

Journal: Signal transduction and targeted therapy

Published: November 03, 2024

Migration of a Surgical Ligation Device to the Appendix Tube After Appendectomy.

Journal: The American journal of gastroenterology

Published: July 22, 2024

The efficacy and safety of lenvatinib plus transarterial chemoembolization in combination with PD-1 antibody in treatment of unresectable recurrent hepatocellular carcinoma: a case series report.

Journal: Frontiers in oncology

Published: January 24, 2023

Programmed cell death protein 1 and tyrosine kinase inhibition plus transcatheter arterial chemoembolization of advanced hepatocellular carcinoma.

Journal: The British journal of surgery

Published: August 17, 2022

The Effect of Metabolic Syndrome on the Outcome of Hepatitis B-Associated Hepatocellular Carcinoma Patients After Hepatectomy: A Multicenter Study.

Journal: Frontiers in oncology

Published: November 08, 2021

Uvangoletin, extracted from Sarcandra glabra, exerts anticancer activity by inducing autophagy and apoptosis and inhibiting invasion and migration on hepatocellular carcinoma cells.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: April 22, 2021